The expression and clinical significance of microRNAs in colorectal cancer detecting. (Q53675321)

17 May 2018

meta-analysis

0 references

title

The expression and clinical significance of microRNAs in colorectal cancer detecting. (English)

1 reference

17 May 2018

1 reference

1 reference

Xiaoyu Yang

1

1 reference

17 May 2018

Jiateng Zhong

2

1 reference

17 May 2018

Yinghua Ji

3

1 reference

17 May 2018

Jinsong Li

4

1 reference

17 May 2018

Yu Jian

5

1 reference

17 May 2018

Jinghang Zhang

6

1 reference

17 May 2018

Wancai Yang

7

1 reference

17 May 2018

publication date

6 December 2014

1 reference

17 May 2018

published in

Tumor Biology

1 reference

17 May 2018

volume

36

1 reference

17 May 2018

issue

4

1 reference

17 May 2018

page(s)

2675-2684

1 reference

17 May 2018

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Identification of microRNA-135b in stool as a potential noninvasive biomarker for colorectal cancer and adenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Conducting systematic reviews of diagnostic studies: didactic guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Serum microRNA-21 as a diagnostic marker for lung carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Circulating miR‐221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Identification and evaluation of plasma microRNAs for early detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Analysis of organ-enriched microRNAs in plasma as an approach to development of Universal Screening Test: feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

A plasma microRNA panel for early detection of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Association between the CYP1A2-164 A/C polymorphism and colorectal cancer susceptibility: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Circulating miR-378 in plasma: a reliable, haemolysis-independent biomarker for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

MicroRNA Expression Profiling of Exfoliated Colonocytes Isolated from Feces for Colorectal Cancer Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Use of microRNAs in directing therapy and evaluating treatment response in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Limited diagnostic value of microRNAs for detecting colorectal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2890-0

Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population

1 reference

12 December 2020

Expression of plasma miR-106a in colorectal cancer and its clinical significance

1 reference

12 December 2020

Plasma miR-21: a potential diagnostic marker of colorectal cancer

1 reference

12 December 2020

Detection of miR-34a and miR-34b/c in stool sample as potential screening biomarkers for noninvasive diagnosis of colorectal cancer

1 reference

12 December 2020

Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma

1 reference

12 December 2020

Global fecal microRNA profiling in the identification of biomarkers for colorectal cancer screening among Asians

1 reference

12 December 2020

10.1007/S13277-014-2890-0

Identifiers

DOI

1 reference

17 May 2018

1 reference

17 May 2018